Corbus Pharmaceuticals Holdings, Inc. (CRBP)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-53.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $881.7K | $3.94M | $36.14M | $4.82M | — | — |
| Operating Income | -$85.31M | -$48.72M | -$45.08M | -$39.84M | -$55.99M | -$122.81M | -$77.10M | -$56.75M | -$32.56M | -$19.99M |
| Net Income | -$78.54M | -$40.21M | -$44.60M | -$42.35M | -$45.64M | -$111.27M | -$71.45M | -$55.67M | -$32.42M | -$20.00M |
| EPS (Diluted) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 | $-1.42 | — | — | — | — |
| Total Assets | $168.19M | $155.88M | $28.27M | $66.31M | $107.73M | $102.29M | $49.14M | $46.99M | $66.98M | $17.89M |
| Total Liabilities | $20.69M | $13.45M | $35.18M | $33.32M | $38.62M | $57.02M | $42.98M | $19.47M | $9.19M | $8.97M |
| Shareholders' Equity | $147.50M | $142.43M | -$6.91M | $32.99M | $69.11M | $45.27M | $6.16M | $27.52M | $57.78M | $8.92M |
| Cash & Equivalents | $28.49M | $17.20M | $13.72M | $17.00M | $25.01M | $85.43M | $31.75M | $41.75M | $62.54M | $14.99M |
| Operating Cash Flow | -$64.49M | -$41.79M | -$36.10M | -$37.54M | -$48.18M | -$99.69M | -$45.72M | -$30.07M | -$27.80M | — |
| Capital Expenditures | $7.0K | $0 | $0 | $13.4K | $54.2K | $484.5K | $2.74M | $2.30M | $707.4K | $353.0K |
| Shares Outstanding | 17.61M | 12.18M | 4.42M | 4.17M | 4.17M | 98.85M | 64.67M | 57.25M | 55.60M | 44.68M |